Assignee
CUBIST PHARM INC
US50 patents
Top patents by PatentIndex Score
US5801013ASep 1, 1998
Helicobacter aminoacyl-tRNA synthetase proteins, nucleic acids and strains comprising same
CUBIST PHARM INC88 citations94
US5798240AAug 25, 1998
Recombinant mycobacterial methionyl-tRNA synthetase genes and methods of use therefore
CUBIST PHARM INC84 citations94
US5759833AJun 2, 1998
Human isoleucyl-tRNA synthetase proteins, nucleic acids and tester strains comprising same
CUBIST PHARM INC93 citations94
US5756327AMay 26, 1998
Recombinant mycobacterial isoleucyl-tRNA synthetase genes, tester strains and assays
CUBIST PHARM INC85 citations94
US6696412B1Feb 24, 2004
High purity lipopeptides, Lipopeptide micelles and processes for preparing same
CUBIST PHARM INC46 citations93
US6475726B1Nov 5, 2002
Method for identifying validated target and assay combinations for drug development
CUBIST PHARM INC68 citations93
US6468967B1Oct 22, 2002
Methods for administration of antibiotics
CUBIST PHARM INC65 citations92
US5885815AMar 23, 1999
Candida isoleucyl-tRNA synthetase proteins, nucleic acids and strains comprising same
CUBIST PHARM INC73 citations92
US8476425B1Jul 2, 2013
Tazobactam arginine compositions
CUBIST PHARM INC19 citations91
US7527807B2May 5, 2009
Compositions and methods for increasing the oral absorption of antimicrobials
CUBIST PHARM INC31 citations91
US6794490B2Sep 21, 2004
Lipopeptides as antibacterial agents
CUBIST PHARM INC45 citations91
US6436694B1Aug 20, 2002
Regulable gene expression in gram-positive bacteria
CUBIST PHARM INC34 citations90
US6852689B2Feb 8, 2005
Methods for administration of antibiotics
CUBIST PHARM INC26 citations89
US6846625B1Jan 25, 2005
Method for identifying validated target and assay combination for drug development
CUBIST PHARM INC25 citations89
US5824657AOct 20, 1998
Aminoacyl sulfamides for the treatment of hyperproliferative disorders
CUBIST PHARM INC25 citations89
US5726195AMar 10, 1998
Aminoacyl adenylate mimics as novel antimicrobial and antiparasitic agents
CUBIST PHARM INC21 citations89
US6221640B1Apr 24, 2001
Enterococcal aminoacyl-trna synthetase proteins, nucleic acids and strains comprising same
CUBIST PHARM INC42 citations86
US8003673B2Aug 23, 2011
Daptomycin for the treatment of biofilm and catheter salvage
CUBIST PHARM INC17 citations83
US7262268B2Aug 28, 2007
Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
CUBIST PHARM INC13 citations83
US9320740B2Apr 26, 2016
Ceftolozane-tazobactam pharmaceutical compositions
CUBIST PHARM INC8 citations82
US8846610B2Sep 30, 2014
Methods for preparing purified lipopeptides
CUBIST PHARM INC4 citations82
US8809314B1Aug 19, 2014
Cephalosporin compound
CUBIST PHARM INC16 citations82
US7335725B2Feb 26, 2008
Lipopeptides as antibacterial agents
CUBIST PHARM INC16 citations82
US6911525B2Jun 28, 2005
Lipopeptides as antibacterial agents
CUBIST PHARM INC15 citations82
US8853357B2Oct 7, 2014
High purity lipopeptides
CUBIST PHARM INC5 citations81
US9193729B2Nov 24, 2015
Inhibiting transient receptor potential ion channel TRPA1
CUBIST PHARM INC6 citations79
US9138456B2Sep 22, 2015
Lipopeptide compositions and related methods
CUBIST PHARM INC6 citations79
US8962843B2Feb 24, 2015
1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors
CUBIST PHARM INC3 citations72
US8916709B2Dec 23, 2014
1,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors
CUBIST PHARM INC4 citations71
US5656470AAug 12, 1997
Recombinant mycobacterial seryl-tRNA synthetase genes, tester strains and assays
CUBIST PHARM INC9 citations71
US5629188AMay 13, 1997
Human alanyl-tRNA synthetase proteins, nucleic acids and tester strains comprising same
CUBIST PHARM INC8 citations68
US9120795B2Sep 1, 2015
Crystalline form of a β-lactamase inhibitor
CUBIST PHARM INC5 citations67
US9006421B2Apr 14, 2015
Cephalosporin compositions and methods of manufacture
CUBIST PHARM INC6 citations64
US7335726B2Feb 26, 2008
Lipopeptide stereoisomers, methods for preparing same and useful intermediates
CUBIST PHARM INC4 citations62
US8969570B2Mar 3, 2015
Beta-lactamase inhibitors
CUBIST PHARM INC3 citations61
US8940897B2Jan 27, 2015
1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors
CUBIST PHARM INC1 citations61
US8933232B2Jan 13, 2015
1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors
CUBIST PHARM INC1 citations61
US8933233B2Jan 13, 2015
1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors
CUBIST PHARM INC1 citations61
US7408025B2Aug 5, 2008
Lipopeptides as antibacterial agents
CUBIST PHARM INC5 citations61
US8962844B2Feb 24, 2015
1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors
CUBIST PHARM INC1 citations60
US8796224B2Aug 5, 2014
Methods for preparing purified lipopeptides
CUBIST PHARM INC2 citations60
US5871987AFeb 16, 1999
Candida tyrosyl-tRNA synthetase proteins, nucleic acids and strains comprising same
CUBIST PHARM INC4 citations60
US8927724B2Jan 6, 2015
Isoxazole beta-lactamase inhibitors
CUBIST PHARM INC3 citations59
US6153645ANov 28, 2000
Heterocycles as antimicrobial agents
CUBIST PHARM INC3 citations58
US5912140AJun 15, 1999
Recombinant pneumocystis carinii aminoacyl tRNA synthetase genes, tester strains and assays
CUBIST PHARM INC5 citations53
US9108966B2Aug 18, 2015
Beta-lactamase inhibitors
CUBIST PHARM INC0 citations50
US7235651B2Jun 26, 2007
Genes and proteins involved in the biosynthesis of lipopeptides
CUBIST PHARM INC0 citations50
US6174713B1Jan 16, 2001
Candida cytoplasmic tryptophanyl-tRNA synthetase proteins, nucleic acids and strains comprising same
CUBIST PHARM INC1 citations49
US9120796B2Sep 1, 2015
B-lactamase inhibitor picoline salt
CUBIST PHARM INC0 citations42
US6784203B1Aug 31, 2004
Cytokine production inhibitors
CUBIST PHARM INC0 citations39